Name | methyl 2,3-dioxo-1,4-dihydroquinoxaline-6-carboxylate |
---|---|
Synonyms |
methyl 2,3-dioxo-1,2,3,4-tetrahydro-6-quinoxalinecarboxylate
6-Quinoxalinecarboxylic acid, 2,3-dihydroxy-, methyl ester methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate Methyl 2,3-dihydroxy-6-quinoxalinecarboxylate 2,3-dioxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid methyl ester |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 511.2±45.0 °C at 760 mmHg |
Molecular Formula | C10H8N2O4 |
Molecular Weight | 220.182 |
Flash Point | 263.0±28.7 °C |
Exact Mass | 220.048401 |
PSA | 92.02000 |
LogP | 2.65 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.698 |
HS Code | 2933990090 |
---|
~% 354793-04-7 |
Literature: Pfizer Inc. Patent: US2004/192698 A1, 2004 ; Location in patent: Page/Page column 18 ; |
Precursor 2 | |
---|---|
DownStream 1 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |